Shenyang Xingqi Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002DV1
CNY
70.26
0.89 (1.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
683.34
569.12
740.99
626.60
536.14
504.10
547.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
683.34
569.12
740.99
626.60
536.14
504.10
547.49
Raw Material Cost
122.64
120.95
141.23
127.99
116.08
119.09
125.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.48
0.63
1.00
1.30
1.50
1.65
1.80
Selling and Distribution Expenses
241.88
255.88
228.42
233.48
199.82
233.92
220.65
Other Expenses
8.40
6.53
5.75
3.96
4.18
7.65
5.60
Total Expenditure (Excl Depreciation)
449.00
442.78
428.17
402.40
359.21
431.16
403.93
Operating Profit (PBDIT) excl Other Income
234.3
126.30000000000001
312.8
224.20000000000002
176.9
72.9
143.6
Other Income
5.53
-0.84
2.98
-5.85
16.15
-8.15
5.01
Operating Profit (PBDIT)
230.60
142.65
335.58
235.14
205.70
85.27
165.80
Interest
0.48
0.63
1.00
1.30
1.50
1.65
1.80
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
560.69
448.17
599.76
498.61
420.06
385.01
421.98
Depreciation
0.00
30.51
30.51
26.66
26.66
26.46
26.46
Profit Before Tax
230.12
111.50
304.06
207.17
177.53
57.17
137.53
Tax
23.71
14.56
39.98
18.24
31.64
9.87
16.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
206.41
96.95
264.08
188.93
145.90
47.30
121.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
206.41
96.95
264.08
188.93
145.90
47.30
121.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
206.41
96.95
264.08
188.93
145.90
47.30
121.44
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,185.10
1,978.05
1,857.29
1,758.16
1,743.26
1,593.17
1,627.76
Earnings per share (EPS)
0.84
0.39
1.08
0.77
0.59
0.19
0.5
Diluted Earnings per share
0.84
0.39
1.08
0.77
0.59
0.19
0.5
Operating Profit Margin (Excl OI)
32.94%
19.85%
40.77%
34.2%
30.38%
13.28%
24.53%
Gross Profit Margin
33.68%
24.95%
45.15%
37.32%
38.09%
16.59%
29.95%
PAT Margin
30.21%
17.03%
35.64%
30.15%
27.21%
9.38%
22.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 27.46% vs 55.03% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 41.47% vs 320.46% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 18.72% vs 193.04% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -66.67% vs 150.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Shenyang Xingqi Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
683.34
0
683.34
Other Operating Income
0.00
0.00
0.00
Total Operating income
683.34
0
683.34
Raw Material Cost
122.64
0
122.64
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.48
0
0.48
Selling and Distribution Expenses
241.88
0
241.88
Other Expenses
8.40
0.00
8.40
Total Expenditure (Excl Depreciation)
449.00
0
449.00
Operating Profit (PBDIT) excl Other Income
234.34
0.00
234.34
Other Income
5.53
0
5.53
Operating Profit (PBDIT)
230.60
0
230.60
Interest
0.48
0
0.48
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
560.69
0
560.69
Depreciation
0.00
0
0.00
Profit Before Tax
230.12
0
230.12
Tax
23.71
0
23.71
Provisions and contingencies
0
0
0.00
Profit After Tax
206.41
0
206.41
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
206.41
0
206.41
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
206.41
0
206.41
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,185.10
0
2,185.10
Earnings per share (EPS)
0.84
0
0.84
Diluted Earnings per share
0.84
0
0.84
Operating Profit Margin (Excl OI)
32.94%
0%
0.00
32.94%
Gross Profit Margin
33.68%
0%
0.00
33.68%
PAT Margin
30.21%
0%
0.00
30.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 68.33 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 20.07% vs -23.20% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 27.46% vs 55.03% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.64 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 113.00% vs -63.31% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 41.47% vs 320.46% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.51 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 56.86% vs -56.86% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 18.72% vs 193.04% in Mar 2025

Quarterly - Interest
Interest 0.05 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -16.67% vs -40.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -66.67% vs 150.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.94%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025